DBV Technologies (DBVT) Non-Current Debt (2015 - 2020)

DBV Technologies (DBVT) posted quarterly Non-Current Debt of $831844.6 for Q2 2020, down 27.12% year-on-year from $1.1 million in Q3 2019, and up 1.39% on a QoQ basis from $820465.0 in Q4 2019.

DBV Technologies (DBVT) Non-Current Debt (2015 - 2020) Analysis & Trends

DBV Technologies (DBVT) has reported Non-Current Debt for 6 consecutive years, with $831844.6 the latest figure, recorded in Q2 2020.

  • Quarterly Non-Current Debt fell 27.12% year-over-year to $831844.6 in Q2 2020, while the trailing twelve-month figure through Jun 2020 was $831844.6 (down 27.12% YoY) and the FY2019 annual result came in at $820465.0, down 43.58% from the prior year.
  • Non-Current Debt improved to $831844.6 in Q2 2020 per DBVT's latest filing, from $820465.0 in the prior quarter.
  • Over the last five years, Non-Current Debt for DBVT reached as high as $5.8 million in Q4 2016 and fell as low as $820465.0 in Q4 2019.
  • A 5-year average of $2.1 million and a median of $1.3 million in 2019 frame the typical range for Non-Current Debt.
  • Annual changes were most pronounced in 2016 — Non-Current Debt retreated 13.72% — and 2017, when it tumbled 54.93%.
  • Year by year, Non-Current Debt stood at $5.8 million in 2016, then slumped by 54.93% to $2.6 million in 2017, then tumbled by 44.78% to $1.5 million in 2018, then plunged by 43.58% to $820465.0 in 2019, then gained by 1.39% to $831844.6 in 2020.
  • According to Business Quant data, Non-Current Debt over the past three periods registered $831844.6, $820465.0, and $1.1 million for Q2 2020, Q4 2019, and Q2 2019 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 105.94 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 842.92 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 1.99 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 DBV Technologies 267.50 Mn 92.60 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2020 831,844.57
Dec 31, 2019 820,465.03
Jun 30, 2019 1.14 Mn
Dec 31, 2018 1.45 Mn
Dec 31, 2017 2.63 Mn
Dec 31, 2016 5.84 Mn
Dec 31, 2015 6.77 Mn